Citations

Mayo Clinic

Showing 10 of 108551 citations.

Impact of Unplanned Readmission on Patient-Reported Outcomes After Cervical Spine Surgery: A National Study of 13 355 Patients
Croft, Andrew J. , Vaughan, Wilson E. , Khan, Inamullah , Davidson, Claudia , Bydon, Mohammad, Asher, Anthony L. , Archer, Kristin R. , Berkman, Richard A., Abtahi, Amir M. , Zuckerman, Scott L , Pennings, Jacquelyn S. , Chanbour, Hani , Gardocki, Raymond J. , Stephens, Byron F. , Zuckerman, Scott L.

Neurosurgery | February 21, 2024 | Volume: 95 | Issue: 1 | Pages: 234-249

10.1227/neu.0000000000002872 | PMID 38380924 Get It

BACKGROUND AND OBJECTIVES: Although risk factors for unplanned readmission after cervical spine surgery have been widely reported, less is known about how readmission itself affects patient-reported outcome measures (PROMs). Using the Quality Outcomes Database registry of patients undergoing elective cervical spine surgery, we sought to (1) determine the impact of unplanned readmission on PROMs and (2) compare the effect of specific readmission reasons on PROMs. METHODS: An observational study was performed using a multi-institution, retrospective registry for patients undergoing cervical spine surgery. The occurrence of 90-day unplanned readmission classified into medical, surgical, pain only, and no readmissions was the exposure variable. Outcome variables included 12-month PROMs of Neck Disability Index (NDI), Numeric Rating Scale (NRS)-neck/arm pain, EuroQol-5D (EQ-5D), and patient dissatisfaction. Multivariable models predicting each PROM were built using readmission reasons controlling for demographics, clinical characteristics, and preoperative PROMs. RESULTS: Data from 13 355 patients undergoing elective cervical spine surgery (82% anterior approach and 18% posterior approach) were analyzed. Unplanned readmission within 90 days of surgery occurred in 3.8% patients, including medical (1.6%), surgical (1.8%), and pain (0.3%). Besides medical reasons, wound infection/dehiscence was the most common reason for unplanned readmission for the total cohort (0.5%), dysphagia in the anterior approach (0.6%), and wound infection/dehiscence in the posterior approach (1.5%). Based on multivariable regression, surgical readmission was significantly associated with worse 12-month NDI, NRS-neck pain, NRS-arm pain, EQ-5D, and higher odds of dissatisfaction. Pain readmissions were associated with worse 12-month NDI and NRS-neck pain scores, and worse dissatisfaction. For specific readmission reasons, pain, surgical site infection/wound dehiscence, hematoma/seroma, revision surgery, deep vein thrombosis, and pulmonary embolism were significantly associated with worsened 12-month PROMs. CONCLUSION: In patients undergoing elective cervical spine surgery, 90-day unplanned surgical and pain readmissions were associated with worse 12-month PROMs compared with patients with medical readmissions and no readmissions.
Hemophagocytic Lymphohistiocytosis (HLH) in Patients with Tick-Borne Illness: A Scoping Review of 98 Cases
Jevtic, Dorde , Silva, Marilia Dagnon da , Haylock, Alberto Busmail, Nordstrom, Charles W. , Oluic, Stevan , Pantić, Nikola , Nikolajevic, Milan , Nikolajevic, Nikola , Kotseva, Magdalena , Dumic, Igor , Dagnon da Silva, Marilia , Dumic, Igor , Jevtic, Djordje

Infectious Disease Reports | February 21, 2024 | Volume: 16 | Issue: 2 | Pages: 154-169

10.3390/idr16020012 | PMID 38525759 Get It

Hemophagocytic lymphohistiocytosis (HLH) secondary to tick-borne infections is a rare but potentially life-threatening syndrome. We performed a scoping review according to PRISMA guidelines to systematically analyze the existing literature on the topic. A total of 98 patients were included, with a mean age of 43.7 years, of which 64% were men. Most cases, 31%, were reported from the USA. Immunosuppression was present in 21.4%, with the most common cause being previous solid organ transplantation. Constitutional symptoms were the most common, observed in 83.7% of the patients, while fever was reported in 70.4% of cases. Sepsis was present in 27.6%. The most common laboratory abnormalities in this cohort were thrombocytopenia in 81.6% of patients, while anemia, leukopenia, and leukocytosis were observed in 75.5%, 55.1%, and 10.2%, respectively. Liver enzyme elevation was noted in 63.3% of cases. The H-score was analyzed in 64 patients, with the mean value being 209, and bone marrow analysis was performed in 61.2% of patients. Ehrlichia spp. was the main isolated agent associated with HLH in 45.9%, followed by Rickettsia spp. in 14.3% and Anaplasma phagocytophilum in 12.2%. Notably, no patient with Powassan virus infection or Lyme borreliosis developed HLH. The most common complications were acute kidney injury (AKI) in 35.7% of patients, shock with multiple organ dysfunction in 22.5%, encephalopathy/seizure in 20.4%, respiratory failure in 16.3%, and cardiac complications in 7.1% of patients. Treatment included antibiotic therapy alone in 43.9%, while 5.1% of patients were treated with immunosuppressants alone. Treatment with both antibiotics and immunosuppressants was used in 51% of patients. Appropriate empiric antibiotics were used in 62.2%. In 43.9% of cases of HLH due to tick-borne disease, patients received only antimicrobial therapy, and 88.4% of those recovered completely without the need for immunosuppressive therapy. The mortality rate in our review was 16.3%, and patients who received inappropriate or delayed empiric therapy had a worse outcome. Hence, we suggest empiric antibiotic treatment in patients who are suspected of having HLH due to tick-borne disease or in whom diagnostic uncertainty persists due to diagnostic delay in order to minimize mortality.
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis
Franchini, Massimo , Focosi, Daniele , Cruciani, Mario , Joyner, Michael J. , Senefeld, Jonathon W. , Sullivan, David , Casadevall, Arturo , Senefeld, Jonathon W , Sullivan, David J , Casadevall, Arturo , Franchini, Massimo , Joyner, Michael J , Focosi, Daniele , Cruciani, Mario , Pirofski, Liise‐anne , Shoham, Shmuel

Diseases | February 21, 2024 | Volume: 12 | Issue: 3 | Pages: 41

10.3390/diseases12030041 | PMID 38534965 Get It

Plasma collected from people recovered from COVID-19 (COVID-19 convalescent plasma, CCP) was the first antibody-based therapy employed to fight the pandemic. CCP was, however, often employed in combination with other drugs, such as the antiviral remdesivir and glucocorticoids. The possible effect of such interaction has never been investigated systematically. To assess the safety and efficacy of CCP combined with other agents for treatment of patients hospitalized for COVID-19, a systematic literature search using appropriate Medical Subject Heading (MeSH) terms was performed through PubMed, EMBASE, Cochrane central, medRxiv and bioRxiv. The main outcomes considered were mortality and safety of CCP combined with other treatments versus CCP alone. This review was carried out in accordance with Cochrane methodology including risk of bias assessment and grading of the quality of evidence. Measure of treatment effect was the risk ratio (RR) together with 95% confidence intervals (CIs). A total of 11 studies (8 randomized controlled trials [RCTs] and 3 observational) were included in the systematic review, 4 studies with CCP combined with remdesivir and 6 studies with CCP combined with corticosteroids, all involving hospitalized patients. One RCT reported information on both remdesivir and steroids use with CCP. The use of CCP combined with remdesivir was associated with a significantly reduced risk of death (RR 0.74; 95% CI 0.56–0.97; p = 0.03; moderate certainty of evidence), while the use of steroids with CCP did not modify the mortality risk (RR 0.72; 95% CI 0.34–1.51; p = 0.38; very low certainty of evidence). Not enough safety data were retrieved form the systematic literature analysis. The current evidence from the literature suggests a potential beneficial effect on mortality of combined CCP plus remdesivir compared to CCP alone in hospitalized COVID-19 patients. No significant clinical interaction was found between CCP and steroids.
Characteristics of blood banking/transfusion medicine fellows in the United States, 2013–2021: Lessons learned from the Transfusion Medicine In‐Service Examination (TMISE) practice survey
Karafin, Matthew S. , Tanhehco, Yvette C. , Kreuter, Justin D.

Transfusion | February 21, 2024 | Volume: 64 | Issue: 2 | Pages: 414-415

10.1111/trf.17705 | PMID 38379529 Get It

Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
Joseph‐Mathurin, Nelly , Feldman, Rebecca L. , Lu, Ruijin , Shirzadi, Zahra , Toomer, Carmen, Clair, Junie R. Saint, Ma, Yinjiao , Strain, Jeremy F. , Kilgore, Collin , Chen, Charles D., Gordon, Brian A. , Chen, Gengsheng , Hornbeck, Russ C. , Massoumzadeh, Parinaz , Wang, Qing , Li, Yan , Wang, Guoqiao , Keefe, Sarah , Schultz, Stephanie A. , Preboske, Gregory M., Jack, Clifford R. , Ances, Beau M. , Berman, Sarah , Day, Gregory S. , Fox, Nick C. , Fulham, Michael , Ghetti, Bernardino , Johnson, Keith A. , Xiong, Chengjie , Oh, Hwamee , Perrin, Richard J. , Ringman, John M. , Saykin, Andrew J. , Supnet, Charlene , Vöglein, Jonathan , Yakushev, Igor , Morris, John C. , Chhatwal, Jasmeer P. , Network, for the Dominantly Inherited Alzheimer, Jack, Clifford R , Gordon, Brian A , Saykin, Andrew J , Day, Gregory S , Vöglein, Jonathan , Joseph-Mathurin, Nelly , Xiong, Chengjie , Chen, Charles D , Ances, Beau M , Fox, Nick C , Morris, John C , Ghetti, Bernardino F , Supnet-Bell, Charlene , Berman, Sarah , Clair, Junie Saint, McKay, Nicole S. , Friedrichsen, Karl A. , McCullough, Austin , Li, Yan, Cruchaga, Carlos , Llibre‐Guerra, Jorge J. , Allegri, Ricardo , Brooks, William S. , Cash, David M. , Jucker, Mathias , Klunk, William E. , Fougère, Christian la , Niimi, Yoshiki , Reischl, Gerald , Schofield, Peter R. , Su, Yi , Brickman, Adam M. , McDade, Eric , Xiong, Chengjie , Bateman, Randall J. , Benzinger, Tammie L.S. , Network, for the Dominantly Inherited Alzheimer

Alzheimer's & Dementia | February 21, 2024 | Volume: 20 | Issue: 4 | Pages: 2680-2697

10.1002/alz.13729 | PMID 38380882 Get It

AbstractINTRODUCTIONAmyloidosis, including cerebral amyloid angiopathy, and markers of small vessel disease (SVD) vary across dominantly inherited Alzheimer's disease (DIAD) presenilin‐1 (PSEN1) mutation carriers. We investigated how mutation position relative to codon 200 (pre‐/postcodon 200) influences these pathologic features and dementia at different stages.METHODSIndividuals from families with known PSEN1 mutations (n = 393) underwent neuroimaging and clinical assessments. We cross‐sectionally evaluated regional Pittsburgh compound B‐positron emission tomography uptake, magnetic resonance imaging markers of SVD (diffusion tensor imaging‐based white matter injury, white matter hyperintensity volumes, and microhemorrhages), and cognition.RESULTSPostcodon 200 carriers had lower amyloid burden in all regions but worse markers of SVD and worse Clinical Dementia Rating® scores compared to precodon 200 carriers as a function of estimated years to symptom onset. Markers of SVD partially mediated the mutation position effects on clinical measures.DISCUSSIONWe demonstrated the genotypic variability behind spatiotemporal amyloidosis, SVD, and clinical presentation in DIAD, which may inform patient prognosis and clinical trials.Highlights Mutation position influences Aβ burden, SVD, and dementia. PSEN1 pre‐200 group had stronger associations between Aβ burden and disease stage. PSEN1 post‐200 group had stronger associations between SVD markers and disease stage. PSEN1 post‐200 group had worse dementia score than pre‐200 in late disease stage. Diffusion tensor imaging‐based SVD markers mediated mutation position effects on dementia in the late stage.
Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization
Smith, Johanna L. , Tcheandjieu, Catherine , Dikilitas, Ozan , Iyer, Kruthika , Miyazawa, Kazuo , Hilliard, Austin T. , Lynch, Julie A. , Rotter, Jerome I. , Chen, Yii‐Der Ida , Sheu, Wayne Huey‐Herng , Kanoni, Stavroula , Tsao, Philip S. , Ito, Kaoru , Kosel, Matthew , Schaid, Daniel J. , Chen, Yii-Der Ida , Hilliard, Austin , Lynch, Julie A , Chang, Kyong-Mi , Kanoni, Stavroula , Tsao, Philip S , Ito, Kaoru , Kosel, Matthew , Clarke, Shoa L , Schaid, Daniel J , Assimes, Themistocles L , Kullo, Iftikhar J , Dikilitas, Ozan , Rotter, Jerome I , Chang, Kyong‐Mi , Clarke, Shoa L. , Assimes, Themistocles L. , Kullo, Iftikhar J.

Circulation: Genomic and Precision Medicine | February 21, 2024 | Volume: 17 | Issue: 3 | Pages: No page available

10.1161/circgen.123.004272 | PMID 38380516 Get It

BACKGROUND: Predictive performance of polygenic risk scores (PRS) varies across populations. To facilitate equitable clinical use, we developed PRS for coronary heart disease (CHD; PRS CHD ) for 5 genetic ancestry groups. METHODS: We derived ancestry-specific and multi-ancestry PRS CHD based on pruning and thresholding (PRS PT ) and ancestry-based continuous shrinkage priors (PRS CSx ) applied to summary statistics from the largest multi-ancestry genome-wide association study meta-analysis for CHD to date, including 1.1 million participants from 5 major genetic ancestry groups. Following training and optimization in the Million Veteran Program, we evaluated the best-performing PRS CHD in 176,988 individuals across 9 diverse cohorts. RESULTS: Multi-ancestry PRS PT and PRS CSx outperformed ancestry-specific PRS PT and PRS CSx across a range of tuning values. Two best-performing multi-ancestry PRS CHD (ie, PRS PTmult and PRS CSxmult ) and 1 ancestry-specific (PRS CSxEUR ) were taken forward for validation. PRS PTmult demonstrated the strongest association with CHD in individuals of South Asian ancestry and European ancestry (odds ratio per 1 SD [95% CI, 2.75 [2.41–3.14], 1.65 [1.59–1.72]), followed by East Asian ancestry (1.56 [1.50–1.61]), Hispanic/Latino ancestry (1.38 [1.24–1.54]), and African ancestry (1.16 [1.11–1.21]). PRS CSxmult showed the strongest associations in South Asian ancestry (2.67 [2.38–3.00]) and European ancestry (1.65 [1.59–1.71]), lower in East Asian ancestry (1.59 [1.54–1.64]), Hispanic/Latino ancestry (1.51 [1.35–1.69]), and the lowest in African ancestry (1.20 [1.15–1.26]). CONCLUSIONS: The use of summary statistics from a large multi-ancestry genome-wide meta-analysis improved the performance of PRS CHD in most ancestry groups compared with single-ancestry methods. Despite the use of one of the largest and most diverse sets of training and validation cohorts to date, improvement of predictive performance was limited in African ancestry. This highlights the need for larger genome-wide association study datasets of underrepresented populations to enhance the performance of PRS CHD .
Correction: Adema et al. Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis. Pathogens 2023, 12, 703
Adema, Jennifer L. , Ahiskali, Aileen , Hornback, Krutika Mediwala , Rivera, Christina G. , Mediwala Hornback, Krutika , Rivera, Christina G , Fida, Madiha , Stevens, Ryan W.

Pathogens | February 21, 2024 | Volume: 13 | Issue: 3 | Pages: 190

10.3390/pathogens13030190 | PMID 38535615 Get It

There was an error in the original publication [...]
Enhanced Diaphragm Muscle Function upon Satellite Cell Transplantation in Dystrophic Mice
Azzag, Karim, Yamashita, Aline , Tungtur, Sudheer , Ahlquist, Aaron, Zhan, Wen‐Zhi, Onyebu, Chiemelie , Greising, Sarah M. , Mantilla, Carlos B. , Perlingeiro, Rita C. R. , Yamashita, Aline M S , Tungtur, Sudheer , Mantilla, Carlos B , Perlingeiro, Rita C R , Gransee, Heather M. , Magli, Alessandro

International Journal of Molecular Sciences | February 21, 2024 | Volume: 25 | Issue: 5 | Pages: 2503

10.3390/ijms25052503 | PMID 38473751 Get It

The diaphragm muscle is essential for breathing, and its dysfunctions can be fatal. Many disorders affect the diaphragm, including muscular dystrophies. Despite the clinical relevance of targeting the diaphragm, there have been few studies evaluating diaphragm function following a given experimental treatment, with most of these involving anti-inflammatory drugs or gene therapy. Cell-based therapeutic approaches have shown success promoting muscle regeneration in several mouse models of muscular dystrophy, but these have focused mainly on limb muscles. Here we show that transplantation of as few as 5000 satellite cells directly into the diaphragm results in consistent and robust myofiber engraftment in dystrophin- and fukutin-related protein-mutant dystrophic mice. Transplanted cells also seed the stem cell reservoir, as shown by the presence of donor-derived satellite cells. Force measurements showed enhanced diaphragm strength in engrafted muscles. These findings demonstrate the feasibility of cell transplantation to target the diseased diaphragm and improve its contractility.
In‐utero fetal resuscitation during fetal blood transfusion for severe fetal erythroblastosis developed after chorionic villus sampling
Ruano, Rodrigo , Huber, Carl P., Ruano, Rodrigo , Huber, C., Shazly, Sherif A. , Moise, Kenneth J.

Ultrasound in Obstetrics & Gynecology | February 21, 2024 | Volume: 64 | Issue: 2 | Pages: 263-264

10.1002/uog.27621 | PMID 38379499 Get It

Induction of p16Ink4a Gene Expression in Heme Protein–Induced AKI and by Heme: Pathophysiologic Implications
Nath, Karl A. , Singh, Raman Deep , Croatt, Anthony J., Ackerman, Allan W., Grande, Joseph P. , O’Brien, Daniel R. , Adams, Christopher M. , Kirkland, James L. , Garovic, Vesna D , Tchkonia, Tamara, Kirkland, James L , Adams, Christopher M , Garovic, Vesna D. , Tchkonia, Tamar

Kidney360 | February 21, 2024 | Volume: 5 | Issue: 4 | Pages: 501-514

10.34067/kid.0000000000000395 | PMID 38379160 Get It

Key Points In heme protein–mediated AKI (HP-AKI), a senescence phenotype promptly occurs, and increased expression of p16 Ink4a contributes to HP-AKI. Renal p16 Ink4a expression is induced by hemoglobin, myoglobin, and heme in vivo and in renal epithelial cells exposed to heme in vitro . Impairing the binding or degradation of heme by hemopexin deficiency or heme oxygenase-1 deficiency, respectively, further upregulates p16 Ink4a . Background Understanding the pathogenetic basis for AKI involves the study of ischemic and nephrotoxic models of AKI, the latter including heme protein–mediated AKI (HP-AKI). Recently, interest has grown regarding the role of senescence as a mechanism of kidney injury, including AKI. We examined whether senescence occurs in HP-AKI and potential inducers of and the role of a key driver of senescence, namely, p16 Ink4a , in HP-AKI. Methods The long-established murine glycerol model of HP-AKI was used, and indices of senescence were examined. To evaluate the interaction of heme and p16 Ink4a expression, murine models of genetic deficiency of hemopexin ( HPX ) and heme oxygenase-1 ( HO-1 ) were used. To determine the involvement of p16 Ink4a in HP-AKI, the population of p16 Ink4a -expressing cells was reduced using the INK-ATTAC model. Results Using multiple indices, a senescence phenotype appears in the kidney within hours after the induction of HP-AKI. This phenotype includes significant upregulation of p16 Ink4a . p16 Ink4a is upregulated in the kidney after the individual administration of myoglobin, hemoglobin, and heme, as well as in renal epithelial cells exposed to heme in vitro . Genetic deficiencies of HPX and HO-1 , which, independently, are expected to increase heme content in the kidney, exaggerate induction of p16 Ink4a in the kidney and exacerbate HP-AKI, the latter shown in the present studies involving HPX −/− mice and in previous studies involving HO-1 −/− mice. Finally, reduction in the population of p16 Ink4a -expressing cells in the kidney improves renal function in HP-AKI even within 24 hours. Conclusions The pathogenesis of HP-AKI involves senescence and the induction of p16 Ink4a , the latter driven, in part, by hemoglobin, myoglobin, and heme.